Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition

Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired with MitraClip.